data_1ed0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ed0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 34' ' ' ILE . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 2' ' ' SER . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 34' ' ' ILE . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 2' ' ' SER . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 34' ' ' ILE . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 2' ' ' SER . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 pttp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.5 p -79.62 145.76 32.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.071 0.948 . . . . 0.0 110.347 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.2 m -135.89 103.96 5.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.437 1.495 . . . . 0.0 108.704 -161.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.8 m -118.79 145.09 36.94 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.103 1.361 . . . . 0.0 110.171 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.88 -39.45 19.68 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 124.011 3.141 . . . . 0.0 112.802 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 167.01 23.07 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.249 0.62 . . . . 0.0 110.862 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 m -61.04 -43.76 98.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.495 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -60.8 -35.98 77.85 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.192 0.597 . . . . 0.0 111.482 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.59 -43.38 52.67 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -54.87 -41.49 70.89 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.246 1.018 . . . . 0.0 110.139 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.63 -47.43 75.64 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.361 0.528 . . . . 0.0 110.63 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.28 -45.32 82.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 CA-C-N 118.213 0.46 . . . . 0.0 109.817 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -50.28 -46.72 55.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.746 1.219 . . . . 0.0 109.735 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -67.68 -37.24 82.07 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.15 -39.55 75.28 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.772 0.429 . . . . 0.0 110.309 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.1 t -57.9 -54.5 46.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -54.56 -49.55 70.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.41 0.684 . . . . 0.0 112.179 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.06 -34.6 78.39 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.084 0.554 . . . . 0.0 111.482 -174.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.3 p -79.71 27.41 0.29 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.35 0.66 . . . . 0.0 112.154 171.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.82 23.4 69.15 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.975 1.274 . . . . 0.0 114.417 167.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.22 146.4 31.84 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.271 1.036 . . . . 0.0 109.687 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.36 148.56 61.43 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.55 2.833 . . . . 0.0 112.592 -169.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -52.45 -52.47 63.07 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.952 1.701 . . . . 0.0 114.975 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.9 -42.17 25.82 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.037 1.825 . . . . 0.0 112.119 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.5 m -59.62 -45.29 92.39 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.535 0.334 . . . . 0.0 110.459 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.2 m -64.75 -40.28 95.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.216 0.606 . . . . 0.0 110.812 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.86 -37.12 73.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.289 0.636 . . . . 0.0 110.718 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.7 -27.13 19.19 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.33 -42.2 86.26 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.0 p -83.79 -34.7 24.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.607 1.163 . . . . 0.0 112.614 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.98 17.55 65.05 Favored Glycine 0 CA--C 1.535 1.299 0 CA-C-O 119.263 -0.743 . . . . 0.0 112.248 -166.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.4 m -73.38 171.8 12.41 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.517 1.159 . . . . 0.0 110.116 166.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.42 173.0 14.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.418 1.487 . . . . 0.0 108.435 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.2 mm -133.3 128.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.729 0.411 . . . . 0.0 110.096 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.02 170.22 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.266 1.026 . . . . 0.0 110.418 171.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.4 m -75.34 -38.28 60.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.467 1.107 . . . . 0.0 110.806 167.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.88 133.39 40.68 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.222 1.391 . . . . 0.0 112.988 -172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 m -54.27 -44.68 72.07 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.627 1.571 . . . . 0.0 111.385 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -110.75 151.9 27.23 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.204 1.002 . . . . 0.0 110.369 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.8 m -95.45 163.97 20.2 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 126.837 2.055 . . . . 0.0 109.679 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -65.37 165.26 22.97 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.348 2.032 . . . . 0.0 111.723 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -61.26 -21.93 64.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.14 1.376 . . . . 0.0 113.17 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -89.63 -20.57 23.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.124 0.969 . . . . 0.0 112.886 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -129.72 53.56 11.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.267 0.939 . . . . 0.0 111.805 175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.84 -31.73 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.841 2.361 . . . . 0.0 113.322 -166.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.721 -1.133 . . . . 0.0 110.011 -166.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -83.23 144.42 29.77 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.635 1.174 . . . . 0.0 110.739 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 47.1 m -147.91 111.34 4.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.957 0.503 . . . . 0.0 109.858 -158.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.2 m -118.39 152.35 50.76 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.226 1.01 . . . . 0.0 111.807 -165.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.73 -38.04 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.402 2.735 . . . . 0.0 111.908 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -139.54 164.37 30.09 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.016 0.926 . . . . 0.0 110.138 -170.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -63.29 -44.72 94.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.144 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.76 -33.81 75.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.52 -43.85 59.89 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -55.73 -41.1 73.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.924 0.89 . . . . 0.0 110.137 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.46 -47.15 74.03 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 119.237 -0.411 . . . . 0.0 110.646 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 -45.03 83.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.239 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -50.73 -45.96 58.86 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 124.591 1.157 . . . . 0.0 109.97 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -68.34 -38.96 82.02 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.309 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.92 97.46 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.846 0.458 . . . . 0.0 109.886 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.4 t -57.77 -53.91 52.83 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.577 1.151 . . . . 0.0 109.772 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.46 -48.78 73.98 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.299 0.64 . . . . 0.0 112.074 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 mt -59.82 -37.76 80.1 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.221 1.009 . . . . 0.0 111.285 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.81 30.29 0.31 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.061 0.544 . . . . 0.0 112.057 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.19 21.56 70.16 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.134 1.35 . . . . 0.0 114.611 165.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.63 145.9 30.37 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.312 1.056 . . . . 0.0 109.733 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.53 158.25 40.2 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.563 2.842 . . . . 0.0 111.981 -169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -55.25 -47.25 99.01 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.596 -171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.15 -46.56 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.653 2.236 . . . . 0.0 112.293 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.2 m -61.26 -47.49 85.79 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.51 -39.45 91.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.352 0.661 . . . . 0.0 110.53 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.56 76.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.713 0.805 . . . . 0.0 110.54 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -91.19 -24.56 19.88 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.88 -42.31 93.47 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.23 -36.14 21.14 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.694 1.197 . . . . 0.0 112.617 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 6.11 65.9 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.534 -1.148 . . . . 0.0 112.851 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.1 m -64.87 164.51 12.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.547 1.673 . . . . 0.0 110.512 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -124.18 162.69 23.11 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.464 1.506 . . . . 0.0 108.891 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mm -132.13 108.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -168.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 pt -120.21 170.94 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.933 0.893 . . . . 0.0 110.421 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.3 m -75.51 -33.74 60.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.3 1.04 . . . . 0.0 110.857 169.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.94 132.81 52.74 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.346 0.974 . . . . 0.0 112.481 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 m -57.85 -44.15 86.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.602 1.561 . . . . 0.0 111.085 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -105.41 159.34 15.99 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.134 0.974 . . . . 0.0 109.942 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 81.6 m -96.17 160.02 30.81 Favored Pre-proline 0 N--CA 1.451 -0.425 0 C-N-CA 126.561 1.944 . . . . 0.0 109.78 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -79.48 171.83 15.33 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.929 1.753 . . . . 0.0 110.573 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 m -54.59 -34.03 61.32 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.515 1.126 . . . . 0.0 112.336 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -72.04 -18.17 61.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.997 0.919 . . . . 0.0 113.215 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -133.57 75.13 69.55 Favored Pre-proline 0 C--N 1.345 0.381 0 CA-C-N 119.316 0.962 . . . . 0.0 109.8 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -86.11 10.78 3.53 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.925 2.417 . . . . 0.0 113.273 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.558 -1.687 . . . . 0.0 110.949 -177.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.6 pttp . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -76.75 140.41 40.78 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.726 0.811 . . . . 0.0 109.756 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.6 m -131.66 107.77 9.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.248 1.819 . . . . 0.0 108.82 -163.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.6 142.59 31.83 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 124.07 0.948 . . . . 0.0 110.324 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.14 -50.36 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 124.233 3.289 . . . . 0.0 112.81 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -147.85 167.88 23.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.619 0.767 . . . . 0.0 111.087 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.8 m -60.09 -39.43 86.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.062 1.345 . . . . 0.0 110.433 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -59.58 -36.79 76.94 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 122.948 0.499 . . . . 0.0 111.196 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.63 -42.19 55.37 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -54.17 -41.72 68.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.675 0.79 . . . . 0.0 110.283 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -65.78 -46.5 78.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.216 0.462 . . . . 0.0 110.632 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -45.15 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 118.111 0.414 . . . . 0.0 110.052 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.72 -45.87 58.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.91 1.284 . . . . 0.0 109.59 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -66.77 -41.04 88.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.237 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -43.16 98.93 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -58.32 -54.37 47.81 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.48 1.112 . . . . 0.0 109.922 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -55.01 -49.13 72.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.408 0.683 . . . . 0.0 111.759 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.2 mt -60.02 -37.89 81.07 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.424 1.09 . . . . 0.0 111.324 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 p -80.61 30.16 0.3 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.035 0.534 . . . . 0.0 112.018 173.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.08 23.77 68.12 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.195 1.379 . . . . 0.0 114.415 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.48 146.56 31.53 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 118.132 0.966 . . . . 0.0 109.645 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.14 153.01 51.47 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.603 2.869 . . . . 0.0 111.957 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -56.83 -45.3 99.96 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.055 1.342 . . . . 0.0 113.995 -170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.96 -48.48 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.553 2.169 . . . . 0.0 111.753 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 49.2 m -59.78 -45.99 90.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.201 0.6 . . . . 0.0 110.532 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.3 m -65.44 -40.24 93.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.227 0.611 . . . . 0.0 110.806 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.55 75.68 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.12 0.568 . . . . 0.0 110.582 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -90.07 -28.43 19.03 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.841 0.746 . . . . 0.0 112.689 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.77 -42.0 83.18 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 167.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 94.9 p -83.25 -33.51 26.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.08 19.06 68.0 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 119.087 -0.841 . . . . 0.0 112.126 -166.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 40.3 m -75.87 171.24 14.74 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.367 1.084 . . . . 0.0 109.891 165.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.77 171.12 19.39 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.884 1.673 . . . . 0.0 107.824 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 mm -133.23 127.12 53.92 Favored 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-N 118.093 0.406 . . . . 0.0 109.922 -162.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.6 pt -122.89 168.64 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.861 0.864 . . . . 0.0 110.661 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.6 m -73.34 -38.75 65.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.722 1.209 . . . . 0.0 110.985 167.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.78 133.21 44.17 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.185 1.374 . . . . 0.0 112.853 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 m -53.91 -45.47 71.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.551 1.54 . . . . 0.0 111.309 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.3 t -110.79 153.03 25.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.206 1.002 . . . . 0.0 110.379 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.61 163.07 22.29 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 126.83 2.052 . . . . 0.0 109.782 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -65.81 166.16 21.2 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.564 2.176 . . . . 0.0 111.785 175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.8 p -64.13 -19.84 65.56 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.076 1.35 . . . . 0.0 113.206 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -89.03 -24.01 22.45 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.112 0.965 . . . . 0.0 112.735 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -129.1 53.23 10.94 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 119.206 0.912 . . . . 0.0 111.699 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.1 -29.22 22.58 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.068 2.512 . . . . 0.0 112.962 -169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm . . . . . 0 C--O 1.248 0.985 0 CA-C-O 116.24 -1.838 . . . . 0.0 111.168 -169.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.8 pttp . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -70.05 144.35 52.22 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 123.587 0.755 . . . . 0.0 109.536 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -144.45 98.5 3.21 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -152.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -118.83 144.76 36.29 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 124.548 1.139 . . . . 0.0 111.515 -167.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -34.65 17.93 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.555 3.503 . . . . 0.0 113.188 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -154.61 170.24 21.98 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.176 0.59 . . . . 0.0 110.547 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -41.24 94.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.495 1.118 . . . . 0.0 110.539 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -63.23 -38.84 92.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.072 0.396 . . . . 0.0 110.888 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.83 71.52 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.875 0.75 . . . . 0.0 111.566 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -53.33 -42.11 66.42 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.96 0.904 . . . . 0.0 110.525 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -66.4 -46.79 75.42 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.329 0.513 . . . . 0.0 110.527 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -44.61 82.26 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 118.169 0.441 . . . . 0.0 109.811 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -50.99 -46.93 61.54 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.795 1.238 . . . . 0.0 109.634 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -66.84 -40.4 87.95 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.163 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.33 95.59 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.892 0.477 . . . . 0.0 109.878 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.8 t -57.76 -54.46 46.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.637 1.175 . . . . 0.0 109.643 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -55.96 -48.84 75.04 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.2 0.6 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 mt -59.68 -38.07 80.54 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.332 1.053 . . . . 0.0 111.405 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.0 p -80.38 29.86 0.29 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.981 0.512 . . . . 0.0 112.048 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.88 24.0 67.97 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.152 1.358 . . . . 0.0 114.357 167.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.26 144.56 28.01 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 118.119 0.96 . . . . 0.0 109.624 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.16 151.66 61.27 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.584 2.856 . . . . 0.0 111.869 -171.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -60.97 -40.5 74.81 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -168.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.31 -42.1 18.76 Favored 'Trans proline' 0 C--N 1.352 0.728 0 CA-C-N 123.393 2.247 . . . . 0.0 111.551 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 m -60.21 -46.29 90.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.968 0.507 . . . . 0.0 110.241 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.0 m -65.9 -40.28 91.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.303 0.641 . . . . 0.0 110.615 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.58 77.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.388 0.675 . . . . 0.0 110.625 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.72 -25.55 19.97 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.6 -42.22 87.64 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 166.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.2 p -85.16 -34.55 22.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.666 1.186 . . . . 0.0 113.037 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.18 67.53 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.153 -0.804 . . . . 0.0 112.455 -165.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 56.4 m -75.78 177.03 7.2 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.606 1.203 . . . . 0.0 110.196 168.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -151.88 179.13 8.72 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.784 1.234 . . . . 0.0 109.023 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -115.48 133.51 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.93 161.73 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.679 0.792 . . . . 0.0 110.2 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 m -70.57 -34.53 72.31 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.641 1.176 . . . . 0.0 111.369 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.7 136.65 50.98 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.444 1.021 . . . . 0.0 112.033 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 p -56.63 -48.56 77.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.153 1.381 . . . . 0.0 110.243 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 t -110.39 155.97 21.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.567 1.147 . . . . 0.0 110.255 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.8 m -97.63 158.54 32.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 126.51 1.924 . . . . 0.0 110.105 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.79 175.35 11.41 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.078 2.519 . . . . 0.0 111.217 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -56.58 -30.4 63.12 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.798 1.239 . . . . 0.0 112.833 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -10.84 59.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.051 0.941 . . . . 0.0 113.165 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.81 72.19 79.98 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 164.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.62 -4.39 15.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.494 2.796 . . . . 0.0 113.692 -166.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.079 -178.302 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 119.273 -0.394 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -81.03 140.16 35.31 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.296 0.638 . . . . 0.0 109.694 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 89.9 m -135.44 104.58 5.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.172 0.989 . . . . 0.0 110.456 -156.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.9 m -119.48 148.94 46.81 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.487 1.115 . . . . 0.0 110.485 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -62.85 -41.88 27.63 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.854 3.036 . . . . 0.0 112.065 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -151.77 170.83 18.8 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.723 0.809 . . . . 0.0 110.695 -173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 m -62.95 -38.73 92.22 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.274 1.03 . . . . 0.0 110.541 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -62.27 -37.89 87.21 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.219 0.463 . . . . 0.0 110.787 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.63 -43.22 77.29 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 123.805 0.717 . . . . 0.0 111.72 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.4 tpp180 -54.49 -41.38 69.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 117.739 0.77 . . . . 0.0 110.454 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -66.53 -46.77 75.05 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.053 0.388 . . . . 0.0 110.513 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -45.79 78.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 118.16 0.437 . . . . 0.0 109.922 -176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -49.46 -47.03 48.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.59 1.156 . . . . 0.0 109.857 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -67.19 -38.85 86.06 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.226 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.71 -44.75 95.42 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.1 t -57.82 -52.76 64.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.655 1.182 . . . . 0.0 110.295 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.31 -46.83 79.67 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.577 0.751 . . . . 0.0 111.872 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.53 -36.84 79.39 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.039 0.936 . . . . 0.0 111.266 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.0 p -80.13 30.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.946 0.498 . . . . 0.0 112.022 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.23 22.84 67.58 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.25 1.405 . . . . 0.0 114.651 166.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.82 145.34 29.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 118.215 1.007 . . . . 0.0 109.583 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.17 160.16 36.53 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.586 2.857 . . . . 0.0 111.63 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -54.19 -46.99 98.65 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-O 116.834 -1.555 . . . . 0.0 114.083 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.58 -43.03 54.42 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.596 2.197 . . . . 0.0 112.706 -176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.5 m -66.58 -49.67 65.63 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.228 0.611 . . . . 0.0 110.348 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.48 -38.47 87.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.788 0.835 . . . . 0.0 110.699 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.13 69.84 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 109.287 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.48 -16.72 28.41 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.5 tp -62.84 -43.88 97.63 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 93.5 p -86.7 -32.12 20.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.684 1.194 . . . . 0.0 113.937 -174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.98 3.91 72.78 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.851 -164.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -76.34 179.16 5.98 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.806 1.303 . . . . 0.0 111.005 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -169.32 -175.05 2.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.037 1.735 . . . . 0.0 108.074 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 mm -132.92 139.27 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.792 1.237 . . . . 0.0 108.097 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.8 pt -122.92 160.13 25.92 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.756 0.707 . . . . 0.0 111.022 161.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -75.17 -14.64 60.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.495 1.118 . . . . 0.0 112.828 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.9 163.5 10.21 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.286 0.946 . . . . 0.0 112.388 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.3 p -62.71 -45.22 93.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.709 0.804 . . . . 0.0 109.631 170.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -109.28 176.64 5.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.573 1.549 . . . . 0.0 109.276 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.7 m -97.47 167.46 11.8 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 126.74 2.016 . . . . 0.0 109.085 166.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.3 165.66 19.2 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.484 2.123 . . . . 0.0 111.247 167.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -61.08 -25.13 66.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.889 1.275 . . . . 0.0 112.991 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -86.63 -16.19 37.44 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.79 0.836 . . . . 0.0 113.143 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -129.0 61.39 56.58 Favored Pre-proline 0 C--N 1.346 0.414 0 CA-C-N 119.099 0.863 . . . . 0.0 111.189 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -71.6 -30.35 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.003 2.469 . . . . 0.0 112.797 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? . . . . . 0 C--O 1.251 1.148 0 CA-C-O 115.829 -2.034 . . . . 0.0 112.758 -168.387 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -68.99 150.52 47.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 153.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.65 93.75 2.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -154.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.1 m -117.06 145.23 35.23 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.852 1.261 . . . . 0.0 111.037 -167.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.81 -33.29 21.06 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.447 3.431 . . . . 0.0 113.717 -171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -155.29 173.14 17.05 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.169 0.588 . . . . 0.0 110.526 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.8 m -59.95 -42.67 94.55 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.144 0.978 . . . . 0.0 110.424 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.0 m -64.9 -37.34 87.32 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.996 0.362 . . . . 0.0 110.897 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.91 -43.51 73.31 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.824 0.726 . . . . 0.0 111.502 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -54.89 -41.76 71.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.736 0.814 . . . . 0.0 110.307 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -66.11 -46.63 76.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.301 0.501 . . . . 0.0 110.658 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -44.89 81.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-N 118.206 0.457 . . . . 0.0 109.792 -177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.0 -46.37 61.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.662 1.185 . . . . 0.0 109.743 174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.97 -40.49 87.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.181 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.97 96.65 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.916 0.486 . . . . 0.0 109.923 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.0 -54.0 51.84 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.559 1.143 . . . . 0.0 109.753 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.87 -48.62 75.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.186 0.594 . . . . 0.0 112.016 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.57 -38.03 80.07 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -80.69 30.11 0.31 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.051 0.54 . . . . 0.0 112.055 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 65.29 22.54 69.32 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.142 1.353 . . . . 0.0 114.514 166.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.53 145.09 28.93 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.279 1.04 . . . . 0.0 109.662 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.27 157.66 45.6 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.628 2.885 . . . . 0.0 111.908 -169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -56.13 -47.08 99.55 Favored Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-O 117.197 -1.382 . . . . 0.0 113.738 -171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 -46.82 22.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.57 2.18 . . . . 0.0 112.204 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.9 m -61.48 -47.53 85.24 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.244 0.617 . . . . 0.0 110.454 -178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.4 m -65.78 -39.87 91.43 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.426 0.69 . . . . 0.0 110.57 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.782 0.833 . . . . 0.0 110.515 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.9 -25.72 19.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.723 0.692 . . . . 0.0 112.79 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.1 tp -58.85 -42.26 88.91 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 166.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -84.99 -34.88 22.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.642 1.177 . . . . 0.0 112.98 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.49 17.83 63.38 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.486 -165.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.4 m -75.56 173.93 10.36 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.604 1.202 . . . . 0.0 110.292 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.14 178.07 8.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.844 1.258 . . . . 0.0 109.085 168.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.84 125.7 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.417 1.087 . . . . 0.0 108.264 -173.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.97 161.38 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.222 1.009 . . . . 0.0 110.19 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -72.47 -36.14 68.4 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.525 1.13 . . . . 0.0 111.128 170.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.29 139.53 47.75 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.733 1.159 . . . . 0.0 112.835 -171.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 p -63.47 -41.81 98.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.311 1.444 . . . . 0.0 110.619 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.8 p -105.76 122.64 46.49 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.738 1.615 . . . . 0.0 109.165 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.2 m -80.92 152.44 71.76 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 123.601 0.761 . . . . 0.0 108.989 167.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.56 174.67 11.83 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.556 2.837 . . . . 0.0 111.292 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.0 m -56.65 -29.03 61.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 112.284 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -60.04 -32.62 71.08 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.556 1.142 . . . . 0.0 111.121 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -130.79 79.11 72.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 110.193 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.28 -31.17 90.07 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.87 3.047 . . . . 0.0 114.642 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.176 -168.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -77.32 138.27 39.25 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 164.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 66.9 m -143.55 115.02 8.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.422 0.689 . . . . 0.0 110.783 -159.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.08 149.45 54.22 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.676 1.19 . . . . 0.0 112.127 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.25 -48.41 15.92 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.094 3.196 . . . . 0.0 113.345 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -150.72 170.28 19.6 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.223 0.609 . . . . 0.0 111.395 -171.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 m -61.49 -40.69 95.47 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.986 1.314 . . . . 0.0 110.887 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -65.76 -35.5 80.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.778 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.41 -43.92 76.05 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 123.823 0.725 . . . . 0.0 111.565 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -54.53 -41.94 70.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.818 0.847 . . . . 0.0 110.359 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.18 -46.04 78.74 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 118.156 0.435 . . . . 0.0 110.776 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -44.75 82.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 118.311 0.505 . . . . 0.0 109.973 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -50.74 -46.47 59.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.722 1.209 . . . . 0.0 109.721 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.99 -40.38 87.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.058 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.28 95.62 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.822 0.449 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.2 t -57.29 -53.08 62.16 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.838 1.255 . . . . 0.0 110.071 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -56.29 -47.49 78.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.36 0.664 . . . . 0.0 111.87 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.7 mt -60.06 -37.11 78.89 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.044 0.938 . . . . 0.0 111.345 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.02 29.74 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.941 0.496 . . . . 0.0 112.069 172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.82 24.19 66.3 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.222 1.391 . . . . 0.0 114.457 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.66 145.05 28.86 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 118.201 1.001 . . . . 0.0 109.452 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.16 158.01 45.74 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.529 2.819 . . . . 0.0 111.807 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -55.87 -47.03 99.61 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-O 117.089 -1.434 . . . . 0.0 113.65 -171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.51 -46.43 24.29 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.598 2.198 . . . . 0.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.1 m -61.88 -47.64 84.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.16 0.584 . . . . 0.0 110.392 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.9 m -66.14 -39.28 89.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.487 0.715 . . . . 0.0 110.56 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.37 -39.98 81.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.05 0.94 . . . . 0.0 110.322 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.84 -24.59 20.22 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.03 -43.27 91.6 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.0 p -85.03 -34.72 22.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.649 1.18 . . . . 0.0 113.342 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.49 12.54 69.53 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.47 -164.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 45.7 m -74.42 176.11 7.09 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.741 1.27 . . . . 0.0 110.339 167.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.04 172.56 17.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.393 1.477 . . . . 0.0 108.402 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.1 mm -130.48 125.27 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -172.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.5 pt -120.74 165.06 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 123.727 0.811 . . . . 0.0 110.788 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.1 m -73.57 -36.16 65.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.921 1.288 . . . . 0.0 111.195 168.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.11 142.52 35.41 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.262 1.41 . . . . 0.0 113.11 -172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 70.5 m -63.96 -38.35 90.78 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 111.066 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 p -110.69 127.7 55.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.6 1.56 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.1 m -68.22 149.61 98.04 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 165.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.04 168.02 25.85 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.681 2.254 . . . . 0.0 111.352 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.6 p -62.2 -21.88 65.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 0.0 112.071 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -63.93 -42.88 97.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.935 1.294 . . . . 0.0 110.367 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -129.57 70.12 81.73 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.235 1.014 . . . . 0.0 110.28 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -83.51 3.03 8.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.233 2.622 . . . . 0.0 114.139 -166.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 119.224 0.92 . . . . 0.0 110.028 176.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 119.96 -0.067 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.5 p -90.45 140.95 29.23 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.862 1.265 . . . . 0.0 111.456 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.9 m -137.39 102.13 4.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.67 0.788 . . . . 0.0 110.549 -156.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.0 m -118.66 148.19 43.74 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 125.617 1.567 . . . . 0.0 110.275 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.82 -43.48 20.27 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.92 3.08 . . . . 0.0 112.279 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -151.5 170.23 20.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.461 0.705 . . . . 0.0 110.925 -171.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -59.84 -40.73 89.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.883 1.273 . . . . 0.0 110.668 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -63.23 -38.45 91.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.024 0.375 . . . . 0.0 110.88 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.83 -43.26 75.35 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 123.718 0.675 . . . . 0.0 111.559 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -54.36 -41.3 68.99 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.657 0.783 . . . . 0.0 110.6 170.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.4 -46.41 76.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 118.144 0.429 . . . . 0.0 110.536 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -44.63 82.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 118.212 0.46 . . . . 0.0 109.822 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -51.15 -45.98 61.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.739 1.215 . . . . 0.0 109.756 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -67.53 -40.04 85.05 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.182 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.88 97.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.822 0.449 . . . . 0.0 109.845 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -57.93 -52.8 64.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.653 1.181 . . . . 0.0 110.05 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.88 -47.58 77.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.392 0.677 . . . . 0.0 111.923 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.14 -37.04 78.89 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.11 0.964 . . . . 0.0 111.377 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.7 p -79.87 29.17 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.929 0.492 . . . . 0.0 112.094 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.95 66.54 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.237 1.398 . . . . 0.0 114.479 167.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.83 146.65 31.68 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 118.27 1.035 . . . . 0.0 109.685 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.83 155.13 43.75 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.462 2.775 . . . . 0.0 112.483 -168.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -46.56 -57.89 7.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.957 1.703 . . . . 0.0 113.987 -177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -58.83 -45.04 31.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.448 2.099 . . . . 0.0 112.76 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.5 m -61.06 -47.48 86.17 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 117.915 0.325 . . . . 0.0 110.482 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.31 -39.28 92.28 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.589 0.756 . . . . 0.0 110.769 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.55 79.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.811 0.844 . . . . 0.0 110.26 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -90.45 -24.87 20.59 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.718 0.69 . . . . 0.0 112.802 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.5 tp -58.96 -42.74 90.58 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 165.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -84.98 -33.86 22.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 113.21 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.69 14.35 70.57 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.356 -165.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.32 179.24 7.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.476 1.138 . . . . 0.0 110.158 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.92 174.44 14.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.269 1.428 . . . . 0.0 108.485 175.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.49 132.1 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 124.825 1.25 . . . . 0.0 108.062 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.4 pt -120.65 167.49 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.609 0.764 . . . . 0.0 110.239 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.7 m -70.74 -36.42 73.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.528 1.131 . . . . 0.0 110.917 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.25 147.37 42.15 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.923 1.249 . . . . 0.0 112.504 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -66.69 -42.34 86.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -111.38 134.92 52.61 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.914 1.686 . . . . 0.0 109.812 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.9 m -78.95 161.26 69.3 Favored Pre-proline 0 N--CA 1.453 -0.281 0 C-N-CA 124.68 1.192 . . . . 0.0 109.279 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -68.97 168.72 19.7 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.2 1.933 . . . . 0.0 110.627 170.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -61.71 -15.25 38.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.661 1.184 . . . . 0.0 112.794 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -67.69 -45.03 76.35 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.446 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.16 61.27 56.17 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.614 0.766 . . . . 0.0 111.916 -172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.79 -28.33 25.25 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.251 2.634 . . . . 0.0 114.064 -168.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.741 -172.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.523 -0.177 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 34' ' ' ILE . 6.3 m -82.38 133.16 35.21 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 124.05 0.94 . . . . 0.0 109.578 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -135.41 107.67 7.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.04 0.936 . . . . 0.0 110.664 -157.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.3 m -119.22 148.01 44.21 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 125.362 1.465 . . . . 0.0 110.599 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -62.38 -43.55 22.31 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 124.002 3.134 . . . . 0.0 112.146 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -152.01 170.94 18.67 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.526 0.731 . . . . 0.0 110.85 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.3 m -59.98 -40.54 89.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.865 1.266 . . . . 0.0 110.737 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.73 -38.26 90.44 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.138 0.426 . . . . 0.0 110.95 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -42.94 74.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 123.769 0.699 . . . . 0.0 111.52 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -54.45 -41.49 69.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.677 0.791 . . . . 0.0 110.547 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -66.12 -46.2 78.42 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.227 0.467 . . . . 0.0 110.568 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -44.54 80.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -50.81 -46.0 59.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.633 1.173 . . . . 0.0 109.696 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -67.63 -39.77 84.66 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.279 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.02 96.79 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -57.72 -52.51 65.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.76 1.224 . . . . 0.0 110.145 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.84 -47.54 77.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.483 0.713 . . . . 0.0 112.007 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 48.6 mt -60.34 -36.82 78.86 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.079 0.952 . . . . 0.0 111.324 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.6 p -80.08 29.66 0.28 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.931 0.492 . . . . 0.0 112.073 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.15 22.53 67.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.277 1.418 . . . . 0.0 114.556 167.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.92 146.38 31.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.265 1.032 . . . . 0.0 109.678 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 153.94 43.3 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.519 2.813 . . . . 0.0 112.188 -169.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -46.82 -57.12 9.65 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 116.952 -1.499 . . . . 0.0 114.452 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.78 -42.73 56.38 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.472 2.114 . . . . 0.0 113.038 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 m -63.04 -48.72 77.52 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.016 0.371 . . . . 0.0 110.376 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 80.4 m -64.5 -37.74 88.59 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.663 0.785 . . . . 0.0 110.804 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.47 76.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.209 1.004 . . . . 0.0 110.215 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.82 -24.71 20.21 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.677 0.671 . . . . 0.0 112.766 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.58 -42.81 93.35 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 165.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.4 p -85.24 -34.23 22.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.807 1.243 . . . . 0.0 113.333 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 15.2 68.09 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 119.418 -0.657 . . . . 0.0 112.396 -164.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.9 m -77.14 178.21 7.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.538 1.169 . . . . 0.0 110.051 167.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.76 15.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.248 1.419 . . . . 0.0 108.478 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 2' ' ' SER . 3.3 mm -130.3 130.19 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.498 1.119 . . . . 0.0 108.4 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 pt -120.77 168.92 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.452 0.701 . . . . 0.0 111.258 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -79.23 -24.77 42.84 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.62 1.168 . . . . 0.0 111.791 171.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.72 158.19 19.66 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.818 1.199 . . . . 0.0 112.516 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.8 p -79.11 -41.59 28.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.578 1.151 . . . . 0.0 108.518 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -114.16 147.3 39.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.827 1.651 . . . . 0.0 108.93 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.8 m -84.91 157.17 60.52 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.863 1.265 . . . . 0.0 109.176 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.19 168.84 22.19 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.246 1.964 . . . . 0.0 110.822 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -62.18 -16.58 53.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.263 1.025 . . . . 0.0 112.306 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -68.94 -42.22 77.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.652 1.181 . . . . 0.0 110.946 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -134.42 58.91 33.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 123.825 0.85 . . . . 0.0 111.533 -172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.3 -26.8 24.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.314 2.676 . . . . 0.0 114.238 -165.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mptt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.7 -1.143 . . . . 0.0 109.463 -173.482 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 p -84.96 137.61 32.99 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 124.913 1.285 . . . . 0.0 110.566 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.0 m -137.48 102.17 4.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.317 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.7 m -118.67 149.82 47.09 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.289 1.436 . . . . 0.0 110.439 -176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -62.74 -43.02 22.49 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.747 2.965 . . . . 0.0 111.868 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -152.81 172.68 16.35 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.686 0.794 . . . . 0.0 110.992 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.9 m -61.14 -38.77 87.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.557 1.143 . . . . 0.0 111.019 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m -63.79 -38.96 93.04 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.561 0.619 . . . . 0.0 110.976 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.47 -43.46 77.64 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.426 -0.669 . . . . 0.0 111.426 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.1 tpp180 -53.27 -41.46 65.56 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.726 0.81 . . . . 0.0 110.883 169.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.24 -46.06 78.44 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.135 0.425 . . . . 0.0 110.496 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.93 -45.38 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 118.205 0.457 . . . . 0.0 109.924 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -49.64 -46.45 49.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.829 1.252 . . . . 0.0 110.023 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -67.53 -39.71 85.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.194 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.78 97.89 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.63 -52.59 65.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.482 1.113 . . . . 0.0 110.153 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -55.72 -47.38 76.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.404 0.682 . . . . 0.0 111.943 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.3 mt -60.18 -37.01 78.89 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.132 0.973 . . . . 0.0 111.292 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 45.4 p -79.97 29.43 0.27 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.937 0.495 . . . . 0.0 112.123 172.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 64.2 22.46 67.15 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.254 1.407 . . . . 0.0 114.531 167.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.99 147.2 32.62 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.233 1.016 . . . . 0.0 109.685 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.99 156.43 38.66 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.514 2.809 . . . . 0.0 112.561 -167.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -47.74 -57.64 9.54 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.891 1.676 . . . . 0.0 114.311 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -59.31 -43.52 40.3 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.355 2.037 . . . . 0.0 112.693 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.3 m -62.7 -48.93 77.1 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 122.744 0.418 . . . . 0.0 110.419 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.21 -39.75 93.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.658 0.783 . . . . 0.0 110.896 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.34 -41.75 85.33 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 123.64 0.776 . . . . 0.0 109.336 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.06 -19.97 24.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.62 -42.37 98.79 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 163.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.2 p -86.26 -32.06 21.33 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 113.698 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.9 72.88 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.596 -165.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.3 m -79.79 177.94 8.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.772 1.286 . . . . 0.0 110.232 169.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.59 173.21 16.47 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.168 1.387 . . . . 0.0 108.6 175.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mm -130.46 129.4 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.685 1.194 . . . . 0.0 108.263 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.9 pt -120.95 167.65 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.863 0.865 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.4 m -73.77 -34.89 64.87 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.687 1.195 . . . . 0.0 110.973 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.44 141.86 34.07 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.172 1.367 . . . . 0.0 112.591 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 p -61.26 -45.45 94.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.105 1.362 . . . . 0.0 110.644 177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 p -111.61 135.19 52.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.118 1.767 . . . . 0.0 109.343 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m -76.9 158.81 79.92 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 124.662 1.185 . . . . 0.0 109.404 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.45 168.58 23.14 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.296 1.997 . . . . 0.0 111.029 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -57.01 -26.56 60.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.911 1.284 . . . . 0.0 111.883 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.71 -43.16 99.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.926 1.29 . . . . 0.0 111.713 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.83 62.85 55.74 Favored Pre-proline 0 C--N 1.343 0.318 0 C-N-CA 123.735 0.814 . . . . 0.0 111.04 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.46 -30.12 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.188 2.592 . . . . 0.0 112.928 -165.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 117.552 -1.213 . . . . 0.0 109.892 -166.454 . . . . . . . . 0 0 . 1 stop_ save_